Can I switch to LUMRYZ if I’m currently on a different oxybate?

Only your doctor can decide if LUMRYZ is right for you. LUMRYZ is approved for the treatment of cataplexy or EDS in adults with narcolepsy.

If you’re currently taking an oxybate, your doctor can switch you to LUMRYZ at the closest dose equal to what you’re taking now.

How should I take LUMRYZ?

With LUMRYZ, you take 1 premeasured packet, once at bedtime. See the Instructions For Use on how to prepare, shake, and take LUMRYZ.

How do I start a conversation with my doctor about LUMRYZ?

To help you start the conversation with your doctor, we created a Doctor Discussion Guide with key questions to ask your doctor and plenty of space to take notes.

How do I start on LUMRYZ?

LUMRYZ is only available after enrollment in the LUMRYZ REMS and RYZUP™. Your doctor starts your enrollment, then you’ll need to fill out a few forms.

Are any financial assistance programs available?

Yes, RYZUP Support Services are dedicated to helping you throughout your treatment journey, including financial assistance services such as co-pays as little as $0 if you’re eligible.*

What are the most common side effects?

The most common side effects reported by participants in the clinical trial were nausea, dizziness, bedwetting, headache, and vomiting.

Starting LUMRYZ™ (sodium oxybate)

Once-at-bedtime LUMRYZ is designed differently

Circle that says 'The first & only' inside

LUMRYZ is the first and only FDA-approved treatment to help improve symptoms of cataplexy or excessive daytime sleepiness (EDS) with a once-at-bedtime dose

Other oxybate options require waking up in the middle of the night to take a second dose.

LUMRYZ contains a unique blend of granules that work in 2 ways:

Image of person pouring medicine into mixing cup with water inside

Each dosage strength comes in a different-color packet.

Immediate-release
granules start working as you fall asleep

Controlled-release
granules start working later in place of waking for a second dose

The active ingredient in LUMRYZ is sodium oxybate.

Sodium oxybate is strongly recommended by the American Academy of Sleep Medicine (AASM) to treat narcolepsy. This is based on evidence that it reduces cataplexy and EDS.

Download the LUMRYZ Digital Brochure for an offline guide.

Download

How does LUMRYZ fit into your bedtime routine?

LUMRYZ should be taken at least 2 hours after eating and should be the last thing you do before going to bed

Each premeasured packet contains your full prescribed dose:

Illustration of person pouring medicine into mixing cup with water inside

PREPARE

at your bedside by pouring water, then adding 1 premeasured packet into the provided mixing cup. Do not use hot water.

Illustration of person shaking LUMRYZ, timer on left indicating 60 seconds

SHAKE

for at least 60 seconds (1 minute).

TAKE

your medicine and lie in bed as you may fall asleep quickly.*

The mixture will taste salty and appear slightly milky with some granules that stick together even when fully mixed.

Watch this step-by-step guide on how to take LUMRYZ:

LUMRYZ offers you:

The potential for less interrupted sleep

No second dose waiting on your nightstand to take in the middle of the night.

Premeasured packets

Contain the prescribed dose each time.

Discreet and convenient travel

Pack the number of dose packets you will need for your trip.

See how LUMRYZ helped treat the daytime symptoms of narcolepsy for these individuals.

Watch now

How to Get LUMRYZ

Once you and your doctor have decided that LUMRYZ is right for you, your doctor’s office will help you enroll in RYZUP Support Services and the LUMRYZ Risk Evaluation and Mitigation Strategy (REMS).

Learn more about the process of getting started on LUMRYZ with RYZUP Support Services

Visit RYZUP Support Services to learn more

Explore how LUMRYZ may help treat your daytime symptoms of narcolepsy

See clinical trial results

Important Safety Information

WARNING: Taking LUMRYZ™ (sodium oxybate) with other central nervous system (CNS) depressants such as medicines used to make you fall asleep, including opioid analgesics, benzodiazepines, sedating antidepressants, antipsychotics, sedating anti-epileptic medicines, general anesthetics, muscle relaxants, alcohol, or street drugs, may cause serious medical problems, including trouble breathing (respiratory depression), low blood pressure (hypotension), changes in alertness (drowsiness), fainting (syncope), and death.

The active ingredient of LUMRYZ (sodium oxybate) is a form of gamma hydroxybutyrate (GHB), a controlled substance. Abuse or misuse of illegal GHB alone or with other CNS depressants (drugs that cause changes in alertness or consciousness) have caused serious side effects. These effects include seizures, trouble breathing (respiratory depression), changes in alertness (drowsiness), coma, and death. Call your doctor right away if you have any of these serious side effects.

Because of these risks, LUMRYZ is available only by prescription and filled through certified pharmacies in the LUMRYZ REMS program. You must be enrolled in the LUMRYZ REMS to receive LUMRYZ. Further information is available at www.LUMRYZREMS.com or by calling 1-877-453-1029.

INDICATIONs

LUMRYZ (sodium oxybate) for extended-release oral suspension is a prescription medicine used to treat the following symptoms in adults with narcolepsy:

sudden onset of weak or paralyzed muscles (cataplexy)

excessive daytime sleepiness (EDS)

It is not known if LUMRYZ is safe and effective in people less than 18 years of age.

Do not take LUMRYZ if you take other sleep medicines or sedatives (medicines that cause sleepiness), drink alcohol, or have a rare problem called succinic semialdehyde dehydrogenase deficiency.

Keep LUMRYZ in a safe place to prevent abuse and misuse. Selling or giving away LUMRYZ may harm others and is against the law. Tell your doctor if you have ever abused or been dependent on alcohol, prescription medicines, or street drugs.

Anyone who takes LUMRYZ should not do anything that requires them to be fully awake or is dangerous, including driving a car, using heavy machinery, or flying an airplane, for at least six (6) hours after taking LUMRYZ. Those activities should not be done until you know how LUMRYZ affects you.

Falling asleep quickly, including while standing or while getting up from the bed, has led to falls with injuries that have required some people to be hospitalized.

LUMRYZ can cause serious side effects, including the following:

Breathing problems, including slower breathing, trouble breathing, and/or short periods of not breathing while sleeping (eg, sleep apnea). People who already have breathing or lung problems have a higher chance of having breathing problems when they take LUMRYZ.

Mental health problems, including confusion, seeing or hearing things that are not real (hallucinations), unusual or disturbing thoughts (abnormal thinking), feeling anxious or upset, depression, thoughts of killing yourself or trying to kill yourself, increased tiredness, feelings of guilt or worthlessness, and difficulty concentrating. Tell your doctor if you have or had depression or have tried to harm yourself. Call your doctor right away if you have symptoms of mental health problems or a change in weight or appetite.

Sleepwalking. Sleepwalking can cause injuries. Call your doctor if you start sleepwalking.

Tell your doctor if you are on a salt-restricted diet or if you have high blood pressure, heart failure, or kidney problems. LUMRYZ contains a lot of sodium (salt) and may not be right for you.

The most common side effects of LUMRYZ in adults include nausea, dizziness, bedwetting, headache, and vomiting. Your side effects may increase when you take higher doses of LUMRYZ. LUMRYZ can cause physical dependence and craving for the medicine when it is not taken as directed. These are not all the possible side effects of LUMRYZ.

For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.